Home LiteratureArticle Details
PMID: 6547150 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Lithocholate glucuronide is a cholestatic agent.

The Journal of clinical investigation ·Vol. 73 ·No. 6 ·1984-06-00 ·Pages 1507-14

Oelberg DG, Chari MV, Little JM, Adcock EW, Lester R

Abstract

Lithocholic acid and its taurine, glycine, and sulfate derivatives are potent cholestatic agents. Lithocholate glucuronide is present in the plasma and urine of patients with cholestatic syndromes, but little is known of its metabolism, excretion, and cholestatic potential. [3 beta-3H]lithocholate 3-O-beta-D-glucuronide was synthesized, and chemical and radiochemical purity were established. The aqueous solubility of lithocholate glucuronide was determined and found to be greater than that of lithocholic acid or several of its derivatives. In the range of concentrations examined, calcium ions precipitated lithocholate glucuronide stoichiometrically. The material was administered to rats prepared with an external biliary fistula. When 17-25 micrograms quantities were administered, 89.1 +/- 4.5% (mean +/- SEM) of the radiolabel was secreted in bile within the first 20 h after administration, the major fraction being secreted in less than 20 min. Four-fifths of the radiolabeled material in bile was the administered unaltered parent compound, while a minor fraction consisted of a more polar derivative(s). We showed that increasing biliary concentrations of more polar derivatives were observed with milligram doses of [3H]lithocholate glucuronide, and with time after the administration of these loading doses. Milligram doses of [3H]lithocholate glucuronide resulted in partial or complete cholestasis. When induced cholestasis was partial, secretion in bile remained the primary excretory route (82.5-105.6% recovery in bile), while, when complete cholestasis was induced, wide tissue distribution of radiolabel was observed. Cholestasis developed rapidly during infusion of [3H]lithocholate glucuronide. Bile flow was diminished within 10-20 min of the start of an infusion of 0.05 mumol, 100 g-1 body weight, minute-1, administered concomitantly with an equimolar infusion of taurocholate. The results establish that lithocholate glucuronide exerts cholestatic effects comparable to those exerted by unconjugated lithocholic acid.

MeSH Terms
Animals Bile/analysis Bile Acids and Salts/isolation & purification Biliary Fistula/metabolism Cholestasis/metabolism Chromatography, Gas/methods Chromatography, High Pressure Liquid/methods Chromatography, Thin Layer/methods Glucuronates/chemical synthesis,metabolism Kinetics Lithocholic Acid/chemical synthesis,metabolism Male Rats Rats, Inbred Strains Tritium
Chemicals
Bile Acids and Salts Glucuronates Tritium Lithocholic Acid lithocholate 3-O-glucuronide
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Oelberg D G
Chari M V
Little J M
Adcock E W
Lester R
References (18)
18 references, click to expand
  1. The formation of lithocholic acid, chenodeoxycholic acid and alpha- and beta-muricholic acids from cholesterol incubated with rat-liver mitochondria.
    Biochem J. 1967 May;103(2):472-9 PMID: 6047622
  2. Constituents of human meconium--I. Identification of 3-hydroxy-etianic acids.
    J Steroid Biochem. 1983 Mar;18(3):341-51 PMID: 6827839
  3. Metabolism of lithocholate in healthy man. II. Enterohepatic circulation.
    Gastroenterology. 1975 Jul;69(1):67-76 PMID: 1097294
  4. Bile salt glucuronides: identification and quantitative analysis in the urine of patients with cholestasis.
    Eur J Clin Invest. 1976 Jan 30;6(1):67-74 PMID: 1253809
  5. Bile acid glucuronides, III[1, 2]. Chemical synthesis and characterization of glucuronic acid coupled mono-, di- and trihydroxy bile acids.
    Hoppe Seylers Z Physiol Chem. 1976 Feb;357(2):219-24 PMID: 1254248
  6. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry.
    J Lipid Res. 1977 May;18(3):339-62 PMID: 864325
  7. Relationships between calcium and cyclic nucleotides in cell activation.
    Physiol Rev. 1977 Jul;57(3):421-509 PMID: 196302
  8. Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats.
    Gastroenterology. 1978 Oct;75(4):595-607 PMID: 213342
  9. Choleretic and cholestatic effects of infused bile salts in the rat.
    Experientia. 1979 Jun 15;35(6):809-11 PMID: 467601
  10. The respective roles of membrane cholesterol and of sodium potassium adenosine triphosphatase in the pathogenesis of lithocholate-induced cholestasis.
    Lab Invest. 1980 Jul;43(1):73-81 PMID: 6248686
  11. Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment.
    Eur J Clin Invest. 1980 Aug;10(4):307-16 PMID: 6775958
  12. Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis.
    Scand J Gastroenterol. 1980;15(5):593-600 PMID: 7444367
  13. Lithocholate cholestasis--sulfated glycolithocholate-induced intrahepatic cholestasis in rats.
    Gastroenterology. 1981 Feb;80(2):233-41 PMID: 7450414
  14. Pathologic versus physiologic cholestasis: elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease.
    J Pediatr. 1981 Mar;98(3):399-402 PMID: 7205448
  15. Increased cholesterol and decreased fluidity of red cell membranes (spur cell anemia) in progressive intrahepatic cholestasis.
    Pediatrics. 1981 Apr;67(4):461-6 PMID: 7254967
  16. Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones.
    J Clin Invest. 1981 Nov;68(5):1190-6 PMID: 7298846
  17. Analysis of bile acid glucuronides in urine: group separation on a lipophilic anion exchanger.
    Clin Chim Acta. 1982 Aug 18;123(3):275-85 PMID: 7116646
  18. Effect of sodium taurolithocholate on bile flow and bile acid exeretion.
    J Clin Invest. 1968 May;47(5):1002-14 PMID: 5645847
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1984-06-00
Pages
1507-14
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC437060
Subset
IM
Grants
NICHD NIH HHS · HD14198 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com